{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T11:59:07Z","timestamp":1795089547117,"version":"4.10.2"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T00:00:00Z","timestamp":1594857600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T00:00:00Z","timestamp":1594857600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>To compare adenocarcinoma (AC) and adenosquamous carcinoma (ASC) prognoses in patients with FIGO stage IB\u2013IIA cervical cancer who underwent radical hysterectomy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We performed a retrospective analysis of 240 patients with AC and 130 patients with ASC. Kaplan\u2013Meier curves, Cox regression models, and log-rank tests were used for statistical analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Patients with ASC had higher frequencies of lymphovascular space invasion (LVSI) and serum squamous cell carcinoma antigen (SCC-Ag)\u2009&gt;\u20095\u2009ng\/ml (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.049 and\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.013, respectively); moreover, they were much older (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.029) than patients with AC. There were no clinically significant differences in overall survival (OS) between the groups. When stratified into three risk groups based on clinicopathological features, survival outcomes did not differ between patients with AC and those with ASC in any risk group. Multivariate analysis showed that lymph node metastasis (LNM) was an independent risk factor for recurrence-free survival (RFS) and OS in patients with AC and in patients with ASC. Carcinoembryonic antigen (CEA)\u2009&gt;\u20095\u2009ng\/ml and SCC-Ag\u2009&gt;\u20095\u2009ng\/ml were independent predictors of RFS and OS in patients with AC. In addition, among those stratified as intermediate-risk, patients with ASC who received concurrent chemoradiotherapy (CCRT) had significantly better RFS and OS (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.036 and\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.047, respectively).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>We did not find evidence to suggest that AC and ASC subtypes of cervical cancer were associated with different survival outcomes. CCRT is beneficial for survival in intermediate-risk patients with ASC, but not in those with AC. Serum tumour markers can assist in evaluating prognosis and in providing additional information for patient-tailored therapy for cervical AC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12885-020-07148-x","type":"journal-article","created":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T08:02:47Z","timestamp":1594886567000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Comparison of adenocarcinoma and adenosquamous carcinoma prognoses in Chinese patients with FIGO stage IB-IIA cervical cancer following radical surgery"],"prefix":"10.1186","volume":"20","author":[{"given":"Xiaojing","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zunfu","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuomin","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4314-3426","authenticated-orcid":false,"given":"Hanmei","family":"Lou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,16]]},"reference":[{"key":"7148_CR1","doi-asserted-by":"crossref","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A, et-al. Global cancer statistics 2018: globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Ca A Cancer J Clin. 2018;68(6):394\u2013424.","DOI":"10.3322\/caac.21492"},{"issue":"6","key":"7148_CR2","doi-asserted-by":"publisher","first-page":"510","DOI":"10.21147\/j.issn.1000-9604.2017.06.05","volume":"29","author":"T Shu","year":"2017","unstructured":"Shu T, Zhao D, Li B, Wang Y, Liu S, Li P, et al. Prognostic evaluation of postoperative adjuvant therapy for operable cervical cancer: 10 years\u2019 experience of National Cancer Center in China. Chin J Cancer Res. 2017;29(6):510\u201320.","journal-title":"Chin J Cancer Res"},{"key":"7148_CR3","volume":"1","author":"A Baalbergen","year":"2013","unstructured":"Baalbergen A, Veenstra Y, Stalpers L. Primary surgery versus primary radiotherapy with or without chemotherapy for early adenocarcinoma of the uterine cervix. Cochrane Database Syst. 2013;1:CD006248.","journal-title":"Cochrane Database Syst"},{"issue":"2","key":"7148_CR4","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1038\/bjc.2013.716","volume":"110","author":"SY Ryu","year":"2014","unstructured":"Ryu SY, Kim MH, Nam BH, Lee TS, Song ES, Park CY, et al. Intermediate-risk grouping of cervical cancer patients treated with radical hysterectomy: a korean gynecologic oncology group study. Br J Cancer. 2014;110(2):278\u201385.","journal-title":"Br J Cancer"},{"issue":"9","key":"7148_CR5","doi-asserted-by":"publisher","first-page":"S96","DOI":"10.1097\/IGC.0000000000000263","volume":"24","author":"H Fujiwara","year":"2014","unstructured":"Fujiwara H, Yokota H, Monk B, Treilleux I, Devouassoux-Shisheboran M, Davis A, et al. Gynecologic cancer intergroup (GCIG) consensus review for cervical adenocarcinoma. Int J Gynecol Cancer. 2014;24(9):S96\u2013S101.","journal-title":"Int J Gynecol Cancer"},{"key":"7148_CR6","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1046\/j.1365-2559.2002.01462.x","volume":"41","author":"RH Young","year":"2002","unstructured":"Young RH, Clement PB. Endocervical adenocarcinoma and its variants: their morphology and differential diagnosis. Histopathology. 2002;41:185\u2013207.","journal-title":"Histopathology."},{"key":"7148_CR7","first-page":"765","volume":"102","author":"PG Chan","year":"2003","unstructured":"Chan PG, Sung HY, Sawaya GF. Changes in cervical cancer incidence after three decades of screening US women less than 30 years old. Obstet Gynecol. 2003;102:765\u201373.","journal-title":"Obstet Gynecol"},{"key":"7148_CR8","doi-asserted-by":"crossref","unstructured":"Vinh-Hung V, Bourgain C, Vlastos G, G\u00e1bor Cserni, Ridder, MD, Storme G, et al. Prognostic value of histopathology and trends in cervical cancer: a seer population study. BMC Cancer; 2007: 7(1), 164\u20130.","DOI":"10.1186\/1471-2407-7-164"},{"issue":"1","key":"7148_CR9","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.ygyno.2012.06.021","volume":"127","author":"S Mabuchi","year":"2012","unstructured":"Mabuchi S, Okazawa M, Matsuo K, Kawano M, Suzuki O, Miyatake T, et al. Impact of histological subtype on survival of patients with surgically-treated stage ia2\u2013iib cervical cancer: adenocarcinoma versus squamous cell carcinoma. Gynecol Oncol. 2012;127(1):114\u201320.","journal-title":"Gynecol Oncol"},{"key":"7148_CR10","unstructured":"National Comprehensive Cancer Network NCCN Clinical Practice Guidelines in Oncology, Cervical Cancer Version 2 (2015)."},{"issue":"3","key":"7148_CR11","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.ygyno.2007.07.080","volume":"107","author":"RD Reis","year":"2007","unstructured":"Reis RD, Frumovitz M, Milam MR, Capp E, Sun CC, Coleman RL, et al. Adenosquamous carcinoma versus adenocarcinoma in early-stage cervical cancer patients undergoing radical hysterectomy: an outcomes analysis. Gynecol Oncol. 2007;107(3):458\u201363.","journal-title":"Gynecol Oncol"},{"issue":"3","key":"7148_CR12","first-page":"633","volume":"49","author":"CH Lai","year":"2013","unstructured":"Lai CH, Chou HH, Chang CJ, Wang CC, Hsueh S, Huang YT, et al. Clinical implications of human papillomavirus genotype in cervical adeno-adenosquamous carcinoma. China J Modern Med. 2013;49(3):633\u201341.","journal-title":"China J Modern Med"},{"key":"7148_CR13","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1038\/sj.bjc.6605048","volume":"100","author":"T Kasamatsu","year":"2009","unstructured":"Kasamatsu T, Onda T, Sawada M, Kato T, Ikeda S, Sasajima Y, et al. Radical hysterectomy for FIGO stage I\u2013IIB adenocarcinoma of the uterine cervix. Br J Cancer. 2009;100:1400\u20135.","journal-title":"Br J Cancer"},{"key":"7148_CR14","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1038\/sj.bjc.6605705","volume":"102","author":"JY Park","year":"2010","unstructured":"Park JY, Kim DY, Kim JH, Kim YM, Kim YT, Nam JH. Outcomes after radical hysterectomy in patients with early-stage adenocarcinoma of uterine cervix. Br J Cancer. 2010;102:1692\u20138.","journal-title":"Br J Cancer"},{"issue":"3","key":"7148_CR15","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1097\/IGC.0b013e31828703fd","volume":"23","author":"S Mabuchi","year":"2013","unstructured":"Mabuchi S, Suzuki O, Kamiura S, Ogawa K, Kimura T, Okazawa M, et al. Impact of the addition of concurrent chemotherapy to pelvic radiotherapy in surgically treated stage IB1-IIB cervical cancer patients with intermediate-risk or high-risk factors: a 13-year experience. Int J Gynecol Cancer. 2013;23(3):567\u201375.","journal-title":"Int J Gynecol Cancer"},{"key":"7148_CR16","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1111\/j.1525-1438.2006.00628.x","volume":"16","author":"KBM Lee","year":"2006","unstructured":"Lee KBM, Lee JM, Park CY, Lee KB, Cho HY, Ha SY. What is the difference between squamous cell carcinoma and adenocarcinoma of the cervix? A matched case\u2013control study. Int J Gynecol Cancer. 2006;16:1569\u201373.","journal-title":"Int J Gynecol Cancer"},{"key":"7148_CR17","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1111\/j.1600-0412.2012.01420.x","volume":"91","author":"JL Chen","year":"2012","unstructured":"Chen JL, Cheng JC, Kuo SH, Chen CA, Lin MC, Huang CY. Outcome analysis of cervical adenosquamous carcinoma compared with adenocarcinoma. Acta Obstet Gynecol Scand. 2012;91:1158\u201366.","journal-title":"Acta Obstet Gynecol Scand"},{"key":"7148_CR18","doi-asserted-by":"crossref","unstructured":"Baek MH, Park JY, Kim D, Suh DS, Nam JH. Comparison of adenocarcinoma and adenosquamous carcinoma in patients with early-stage cervical cancer after radical surgery. Gynecologic Oncol. 2014;135(3):462\u20137.","DOI":"10.1016\/j.ygyno.2014.10.004"},{"issue":"2","key":"7148_CR19","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1097\/IGC.0000000000000063","volume":"24","author":"JY Lee","year":"2014","unstructured":"Lee JY, Lee C, Hahn S, Kim MA, Kim HS, Chung HH, et al. Prognosis of Adenosquamous carcinoma compared with adenocarcinoma in uterine cervical Cancer: a systematic review and meta-analysis of observational studies. Int J Gynecol Cancer Official J Int Gynecol Cancer Soc. 2014;24(2):289.","journal-title":"Int J Gynecol Cancer Official J Int Gynecol Cancer Soc"},{"key":"7148_CR20","doi-asserted-by":"publisher","first-page":"2196","DOI":"10.1002\/cncr.11371","volume":"97","author":"JH Farley","year":"2003","unstructured":"Farley JH, Hickey KW, Carlson JW, Rose GS, Kost ER, Harrison TA. Adenosquamous histology predicts a poor outcome for patients with advanced-stage, but not early-stage, cervical carcinoma. Cancer. 2003;97:2196\u2013202.","journal-title":"Cancer"},{"key":"7148_CR21","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1006\/gyno.2000.5935","volume":"79","author":"T Nakanishi","year":"2000","unstructured":"Nakanishi T, Ishikawa H, Suzuki Y, Inoue T, Nakamura S, Kuzuya K. A comparison of prognoses of pathologic stage Ib adenocarcinoma and squamous cell carcinoma of the uterine cervix. Gynecol Oncol. 2000;79:289\u201393.","journal-title":"Gynecol Oncol"},{"issue":"2","key":"7148_CR22","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.ygyno.2012.01.012","volume":"125","author":"V Galic","year":"2012","unstructured":"Galic V, Herzog TJ, Lewin SN, Neugut AI, Burke WM, Lu YS, et al. Prognostic significance of adenocarcinoma histology in women with cervical cancer. Gynecol Oncol. 2012;125(2):287\u201391.","journal-title":"Gynecol Oncol"},{"key":"7148_CR23","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1053\/ejso.1999.0923","volume":"26","author":"T Irie","year":"2000","unstructured":"Irie T, Kigawa J, Minagawa Y, Itamochi H, Sato S, Akeshima R, et al. Prognosis and clinicopathological characteristics of Ib-IIb adenocarcinoma of the uterine cervix in patients who have had radical hysterectomy. Eur J Surg Oncol. 2000;26:464\u20137.","journal-title":"Eur J Surg Oncol"},{"key":"7148_CR24","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.ijrobp.2010.02.009","volume":"80","author":"YT Huang","year":"2011","unstructured":"Huang YT, Wang CC, Tsai CS, Lai CH, Chang TC, Chou HH, et al. Long-term outcome and prognostic factors for adenocarcinoma\/adenosquamous carcinoma of cervix after definitive radiotherapy. Int J Radiat Oncol Biol Phys. 2011;80:429\u201336.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"7148_CR25","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.ygyno.2009.09.040","volume":"116","author":"LT Gien","year":"2010","unstructured":"Gien LT, Beauchemin MC, Thomas G. Adenocarcinoma: a unique cervical cancer. Gynecol Oncol. 2010;116:140\u20136.","journal-title":"Gynecol Oncol"},{"issue":"6","key":"7148_CR26","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1002\/cncr.20877","volume":"103","author":"ME Sherman","year":"2005","unstructured":"Sherman ME, Wang SS, Carreon J, Devesa SS. Mortality trends for cervical squamous and adenocarcinoma in the United States. Cancer. 2005;103(6):1258\u201364.","journal-title":"Cancer."},{"key":"7148_CR27","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1093\/jnci\/djj067","volume":"98","author":"X Castellsagu\u00e9","year":"2006","unstructured":"Castellsagu\u00e9 X, D\u00edaz M, De Sanjos\u00e9 S, Mu\u00f1oz N, Herrero R, Franceschi S, et al. Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention. J Natl Cancer Inst. 2006;98:303\u201315.","journal-title":"J Natl Cancer Inst"},{"key":"7148_CR28","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1016\/S0140-6736(00)04646-8","volume":"357","author":"P Sasieni","year":"2001","unstructured":"Sasieni P, Adams J. Changing rates of adenocarcinoma and adenosquamous carcinoma of the cervix in England. Lancet. 2001;357:1490\u20133.","journal-title":"Lancet."},{"key":"7148_CR29","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1111\/j.1600-0412.2011.01261.x","volume":"90","author":"CY Huang","year":"2011","unstructured":"Huang CY, You SL, Chen CJ, Cheng WF, Luo HC, Hsieh CY. Incidence of cervical cancer and age-specific survival of small cell cervical carcinoma in Taiwan. Acta Obstet Gynecol Scand. 2011;90:1342\u20139.","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"3","key":"7148_CR30","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.ygyno.2014.01.043","volume":"132","author":"JM Noh","year":"2014","unstructured":"Noh JM, Park W, Kim YS, Kim JY, Kim HJ, Kim J, et al. Comparison of clinical outcomes of adenocarcinoma and adenosquamous carcinoma in uterine cervical cancer patients receiving surgical resection followed by radiotherapy: a multicenter retrospective study (KROG 13-10). Gynecol Oncol. 2014;132(3):618\u201323.","journal-title":"Gynecol Oncol"},{"key":"7148_CR31","doi-asserted-by":"crossref","unstructured":"Chen JL\u2010Y, Cheng JC\u2010H, Kuo S\u2010H, Chen C\u2010A, Lin M\u2010C, Huang C\u2010Y. Outcome analysis of cervical adenosquamous carcinoma compared withadenocarcinoma[J]. Acta Obstetricia Et Gynecologica Scandinavica, 2012; 91(10):1158\u20131166.","DOI":"10.1111\/j.1600-0412.2012.01420.x"},{"issue":"1","key":"7148_CR32","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1159\/000132566","volume":"29","author":"EM Davelaar","year":"2008","unstructured":"Davelaar EM, Lande JVD, Mensdorff-Pouilly SV, Blankenstein MA, Kenemans PA. Combination of serum tumor markers identifies high-risk patients with early-stage squamous cervical Cancer. Tumor Biol. 2008;29(1):9\u201317.","journal-title":"Tumor Biol"},{"key":"7148_CR33","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1200\/JCO.2005.02.123","volume":"23","author":"N Reesink-Peters","year":"2005","unstructured":"Reesink-Peters N, van der Velden J, ten Hoor KA, Boezem HM, de Vries EGE, Schilthuis MS, Mourits MJE, Nijman HW, Aalders JG, Hollema H, Pras E, Duk JM, van der Zee AGJ. Preoperative serum squamous cell carcinoma antigen levels in clinical decision making for patients with early-stage cervical cancer. J Clin Oncol. 2005;23:1455\u201362.","journal-title":"J Clin Oncol"},{"issue":"1","key":"7148_CR34","first-page":"61","volume":"14","author":"K Nakamura","year":"2016","unstructured":"Nakamura K, Kitahara Y, Satoh T, Takei Y, Takano M, Nagao S, et al. Analysis of the effect of adjuvant radiotherapy on outcomes and complications after radical hysterectomy in FIGO stage IB1 cervical cancer patients with intermediate risk factors (GOTIC study). Gynecol Oncol. 2016;14(1):61\u20132.","journal-title":"Gynecol Oncol"},{"key":"7148_CR35","doi-asserted-by":"crossref","unstructured":"Saigo PE, Cain JM, Kim WS, Gaynor JJ, Johnson K, Jr LJ, et al. prognostic factors in adenocarcinoma of the uterine cervix. Cancer. 2004; 92(1):262\u2013267.","DOI":"10.1016\/j.ygyno.2003.09.001"},{"key":"7148_CR36","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.ygyno.2006.03.049","volume":"103","author":"SS Wang","year":"2006","unstructured":"Wang SS, Sherman ME, Silverberg SG, Carreon JD, Lacey JV Jr, Zaino R, et al. Pathological characteristics of cervical adenocarcinoma in a multi-center US-based study. Gynecol Oncol. 2006;103:541\u20136.","journal-title":"Gynecol Oncol"},{"key":"7148_CR37","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.suronc.2016.05.028","volume":"25","author":"NF Twu","year":"2016","unstructured":"Twu NF, Ou YC, Liao CI, Chang WY, Yang LY, Tang YH, et al. Prognostic factors and adjuvant therapy on survival in early-stage cervical adenocarcinoma\/adenosquamous carcinoma after primary radical surgery: a Taiwanese gynecologic oncology group (TGOG) study. Surg Oncol. 2016;25:229\u201335.","journal-title":"Surg Oncol"},{"key":"7148_CR38","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.ygyno.2003.08.020","volume":"91","author":"JS Lea","year":"2003","unstructured":"Lea JS, Coleman RL, Garner EO, Duska LR, Miller DS, Schorge JO. Adenosquamous histology predicts poor outcome in low-risk stage IB1 cervical adenocarcinoma. Gynecol Oncol. 2003;91:558\u201362.","journal-title":"Gynecol Oncol"},{"key":"7148_CR39","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1111\/j.1525-1438.2007.01136.x","volume":"18","author":"KB Lee","year":"2008","unstructured":"Lee KB, Lee JM, Ki KD, Lee SK, Park CY, Ha SY. Comparison of adjuvant chemotherapy and radiation in patients with intermediate risk factors after radical surgery in FIGO stage IB-IIA cervical cancer. Int J Gynecol Cancer. 2008;18:1027\u201331.","journal-title":"Int J Gynecol Cancer"},{"key":"7148_CR40","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1007\/s10147-016-0955-3","volume":"21","author":"M Takekuma","year":"2016","unstructured":"Takekuma M, Kasamatsu Y, Kado N, et al. Adjuvant chemotherapy versus concurrent chemoradiotherapy for high-risk cervical cancer after radical hysterectomy and systematic lymphadenectomy. Int J Clin Oncol. 2016;21:741\u20137.","journal-title":"Int J Clin Oncol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-020-07148-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-020-07148-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-020-07148-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T19:22:41Z","timestamp":1626376961000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-020-07148-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,16]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["7148"],"URL":"https:\/\/doi.org\/10.1186\/s12885-020-07148-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-20226\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-20226\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-20226\/v3","asserted-by":"object"}]},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,16]]},"assertion":[{"value":"30 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The present study was approved by the Ethics Committee of Zhejiang Cancer Hospital, and all participants gave written informed consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"664"}}